MDM2 and liposarcoma: Expected disease-defining gene alterations were detected in several histological subtypes, including MDM2 and CDK4 in liposarcoma, IDH mutations in chondrosarcoma, and alterations related to tyrosine kinases in GIST (KIT, PDGFR).